Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer

Francesca Bersani(Harvard University), Eunjung Lee(Brigham and Women's Hospital), Peter V. Kharchenko(Boston Children's Hospital), Andrew Wei Xu(Harvard University), Mingzhu Liu(Howard Hughes Medical Institute), Kristina Xega(Harvard University), Olivia Mackenzie(Harvard University), Brian W. Brannigan(Harvard University), Ben S. Wittner(Harvard University), Hyunchul Jung(Samsung Medical Center), Sridhar Ramaswamy(Harvard University), Peter J. Park(Brigham and Women's Hospital), Shyamala Maheswaran(Harvard University), David T. Ting(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute)
Proceedings of the National Academy of Sciences
November 2, 2015
Cited by 188Open Access
Full Text

Abstract

Aberrant transcription of the pericentromeric human satellite II (HSATII) repeat is present in a wide variety of epithelial cancers. In deriving experimental systems to study its deregulation, we observed that HSATII expression is induced in colon cancer cells cultured as xenografts or under nonadherent conditions in vitro, but it is rapidly lost in standard 2D cultures. Unexpectedly, physiological induction of endogenous HSATII RNA, as well as introduction of synthetic HSATII transcripts, generated cDNA intermediates in the form of DNA/RNA hybrids. Single molecule sequencing of tumor xenografts showed that HSATII RNA-derived DNA (rdDNA) molecules are stably incorporated within pericentromeric loci. Suppression of RT activity using small molecule inhibitors reduced HSATII copy gain. Analysis of whole-genome sequencing data revealed that HSATII copy number gain is a common feature in primary human colon tumors and is associated with a lower overall survival. Together, our observations suggest that cancer-associated derepression of specific repetitive sequences can promote their RNA-driven genomic expansion, with potential implications on pericentromeric architecture.


Related Papers